Position in ABBV
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$1,144,962
+$176,045 QoQ
Shares Held
4,550
+2.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.49%
of 13F equity value
Holder Rank
#2,426
of 4,153 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Grey Ledge Advisors, LLC holds $20,654,452 across 8 Drug Manufacturers - General names. ABBV ranks #5 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
27,060 | $6,872,428 | |
| 2 | AMGN |
Amgen Inc
|
13,311 | $4,820,179 | |
| 3 | MRK |
Merck & Co., Inc.
|
32,342 | $4,155,947 | |
| 4 | LLY |
ELI LILLY & Co
|
1,255 | $1,505,284 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
4,550 | $1,144,962 | |
| 6 | NVO |
Novo Nordisk A S
|
21,878 | $1,048,831 | |
| 7 | PFE |
Pfizer Inc
|
29,199 | $703,111 | |
| 8 | NVS |
Novartis AG
|
2,576 | $403,710 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,144,962 | 4,550 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $968,917 | 4,455 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $1,021,350 | 4,470 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $1,343,163 | 5,801 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $1,262,401 | 6,801 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $1,422,221 | 6,788 | Shares | Sole | 2025-04-18 | |
| 2024-12-31 | $1,227,018 | 6,905 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $1,361,822 | 6,896 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $964,800 | 5,625 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $1,019,760 | 5,600 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $849,390 | 5,481 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $816,848 | 5,480 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $728,754 | 5,409 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $846,254 | 5,310 | Shares | Sole | 2023-05-18 | |
| 2022-12-31 | $1,690,440 | 10,460 | Shares | Sole | 2023-02-16 | |
| 2022-09-30 | $1,616,693 | 12,046 | Shares | Sole | 2022-10-18 | |
| 2022-06-30 | $1,831,640 | 11,959 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $2,322,874 | 14,329 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $2,025,042 | 14,956 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,245,898 | 11,550 | Shares | Sole | 2021-10-22 | |
| 2021-06-30 | $1,442,467 | 12,806 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $1,191,069 | 11,006 | Shares | Sole | 2021-08-11 | |
| 2020-09-30 | $236,580 | 2,701 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $265,184 | 2,701 | Shares | Sole | 2020-08-18 | |
| 2020-03-31 | $205,789 | 2,701 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||